Valuation: Ovation Science Inc.

Market Cap 11.52L 8L 7L 7L 6L 7.89Cr 11.71L 79.09L 30.88L 3.95Cr 31.03L 30.36L 13Cr P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 13.63L 10L 8L 8L 7L 9.33Cr 13.85L 93.55L 36.52L 4.67Cr 36.71L 35.91L 16Cr EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day-27.39%
1 week+366.67%
Current month+40.00%
6 months+65.09%
Current year+18.64%
1 month 0.01
Extreme 0.007
0.04
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0
Extreme 0.004
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-27.39%+366.67% - - 8L
+0.75%-1.36%+1.04%-7.03% 23TCr
+1.45%+0.17%+36.72% - 5.06TCr
+0.63%+11.75%+82.00% - 1.05TCr
+1.35%+7.86%+36.59%-45.62% 873.05Cr
-0.88%+2.44%+9.71%+3.14% 592.39Cr
-0.55%+0.41%-24.59%-30.91% 546.53Cr
-2.07%-2.54%-1.93%-15.45% 378.16Cr
-0.59%-0.63%-29.43%-46.19% 342.45Cr
+0.65%-1.91%-18.55%-48.97% 248.1Cr
Average -2.59%+0.39%+10.17%-27.29% 3.61TCr
Weighted average by Cap. +0.89%-1.45%+9.39%-9.60%

Financials

2024 2025
Net sales 1L 81.21T 70.39T 65.99T 60.17T 77.51L 1L 8L 3L 38.8L 3L 3L 1.29Cr 67.89T 48.7T 42.21T 39.57T 36.08T 46.48L 68.97T 5L 2L 23.26L 2L 2L 77.61L
Net income -5L -3L -3L -3L -2L -3.12Cr -5L -31.31L -12.22L -1.56Cr -12.29L -12.02L -5.22Cr -6L -5L -4L -4L -3L -4.32Cr -6L -43.32L -16.91L -2.16Cr -17L -16.63L -7.22Cr
Net Debt 3L 2L 2L 2L 1L 1.82Cr 3L 18.2L 7L 90.87L 7L 7L 3.03Cr 2L 2L 1L 1L 1L 1.44Cr 2L 14.47L 6L 72.23L 6L 6L 2.41Cr
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
05/26/05 $0.007500 -79.67% 6,000